Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
300 Brannan St, San Francisco, California, 94107, United States
Cofactor Genomics was founded after the pioneering efforts of the Human Genome Project made high-throughput, affordable human genome sequencing a reality. The founders saw that analyzing RNA offered a number of advantages over the static nature of DNA. Today, Cofactor works in partnership with medical centers, pharma companies, and clinical research organizations to offer the most advanced machine-learning tools, deep databases, and molecular reagents through our Predictive Immune Modeling platform which enables us to match patients with the therapies that will benefit them the most.
Cofactor’s ImmunoPrism platform is a solution for uncovering the immune profile of cancer patients. It utilizes RNA from formalin-fixed paraffin-embedded (FFPE) solid tumor specimens and …
Posted Immune Technology
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 3, 2024 at 11:31am